PYPD
Price
$6.53Alerts
Change
-$0.01 (-0.15%)
Updated
Nov 18, 04:59 PM (EDT)
Capitalization
124.71M
84 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$4.00Alerts
Change
-$0.01 (-0.25%)
Updated
Nov 18, 04:59 PM (EDT)
Capitalization
1.41B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PYPD vs TSHA

PYPD vs TSHA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PYPD vs. TSHA commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYPD is a Buy and TSHA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PYPD with price predictions
Nov 17, 2026

Aroon Indicator for PYPD shows an upward move is likely

PYPD's Aroon Indicator triggered a bullish signal on November 17, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 115 similar instances where the Aroon Indicator showed a similar pattern. In 103 of the 115 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on PYPD as a result. In 113 of 128 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.

The Moving Average Convergence Divergence (MACD) for PYPD just turned positive on October 22, 2026. Looking at past instances where PYPD's MACD turned positive, the stock continued to rise in 44 of 50 cases over the following month. The odds of a continued upward trend are 88%.

PYPD moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PYPD crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Following a +5.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where PYPD advanced for three days, in 179 of 218 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The 10-day RSI Indicator for PYPD moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In 16 of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 49 cases where PYPD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

PYPD broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. PYPD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.147) is normal, around the industry mean (3.592). P/E Ratio (-4.687) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (442.120).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TSHA with price predictions
Nov 17, 2026

Momentum Indicator for TSHA turns negative, indicating new downward trend

TSHA saw its Momentum Indicator move below the 0 level on November 17, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 75 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for TSHA moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for TSHA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TSHA's RSI Indicator exited the oversold zone, 32 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for TSHA just turned positive on October 21, 2026. Looking at past instances where TSHA's MACD turned positive, the stock continued to rise in 39 of 43 cases over the following month. The odds of a continued upward trend are 90%.

Following a +6.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSHA advanced for three days, in 213 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.643) is normal, around the industry mean (3.592). P/E Ratio (-10.561) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (442.120).

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. TSHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
PYPD vs TSHA: Fundamental Ratings
PYPD
TSHA
OUTLOOK RATING
1..100
3019
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3561
P/E GROWTH RATING
1..100
7322
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSHA's Valuation (21) in the null industry is somewhat better than the same rating for PYPD (86). This means that TSHA’s stock grew somewhat faster than PYPD’s over the last 12 months.

TSHA's Profit vs Risk Rating (100) in the null industry is in the same range as PYPD (100). This means that TSHA’s stock grew similarly to PYPD’s over the last 12 months.

TSHA's SMR Rating (98) in the null industry is in the same range as PYPD (100). This means that TSHA’s stock grew similarly to PYPD’s over the last 12 months.

PYPD's Price Growth Rating (35) in the null industry is in the same range as TSHA (61). This means that PYPD’s stock grew similarly to TSHA’s over the last 12 months.

TSHA's P/E Growth Rating (22) in the null industry is somewhat better than the same rating for PYPD (73). This means that TSHA’s stock grew somewhat faster than PYPD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PYPDTSHA
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (PYPD: $6.54 vs. TSHA: $4.00)
Brand notoriety: PYPD and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYPD: 662% vs. TSHA: 51%
Market capitalization -- PYPD: $124.71M vs. TSHA: $1.41B
PYPD [@Biotechnology] is valued at $124.71M. TSHA’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYPD’s FA Score shows that 0 FA rating(s) are green while TSHA’s FA Score has 2 green FA rating(s).

  • PYPD’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 2 green, 3 red.
According to our system of comparison, TSHA is a better buy in the long-term than PYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYPD’s TA Score shows that 6 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • PYPD’s TA Score: 6 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PYPD is a better buy in the short-term than TSHA.

Price Growth

PYPD (@Biotechnology) experienced а +3.65% price change this week, while TSHA (@Biotechnology) price change was -6.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.10%. For the same industry, the average monthly price growth was -10.38%, and the average quarterly price growth was -24.10%.

Reported Earning Dates

PYPD is expected to report earnings on Feb 10, 2027.

TSHA is expected to report earnings on Mar 03, 2027.

Industries' Descriptions

@Biotechnology (-11.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and BCYC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and BCYC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+6.34%
BCYC - PYPD
31%
Poorly correlated
+0.63%
TSHA - PYPD
31%
Poorly correlated
-1.48%
IDYA - PYPD
29%
Poorly correlated
-9.75%
AMLX - PYPD
29%
Poorly correlated
-1.01%
SYRE - PYPD
29%
Poorly correlated
-5.60%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with SLDB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-1.48%
SLDB - TSHA
53%
Loosely correlated
-3.86%
FDMT - TSHA
51%
Loosely correlated
-4.43%
BNTC - TSHA
51%
Loosely correlated
-4.57%
MGTX - TSHA
50%
Loosely correlated
-3.20%
KYTX - TSHA
50%
Loosely correlated
-1.26%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LABX4.340.36
+9.05%
Tradr 2X Long ALAB Daily ETF (LABX)
AMKL2.430.01
+0.41%
Defiance Daily Target 2X Long AMKR ETF (AMKL)
IBMS25.44-0.09
-0.37%
iShares iBonds Dec 2030 Term Muni Bond ETF (IBMS)
MKOR47.12-0.43
-0.90%
Matthews Korea Active ETF (MKOR)
IDEQ32.48-0.38
-1.16%
Lazard Active ETF TR